Study finds "extraordinary" genetic diversity in tumors

03/7/2012 | Reuters

About two-thirds of genetic mutations in samples from primary tumors of kidney cancer patients were different from one another, even if they were taken from the same tumor, a British study revealed. Researchers also found even more genetic differentiation in biopsies of secondary tumors. The findings in the New England Journal of Medicine suggest that using samples from a primary tumor as a basis for treatment decisions may not be sufficient, researchers said.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health